My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 132

    1.

    Variants of the insulin receptor substrate-1 and fatty acid binding protein 2 genes and the risk of type 2 diabetes, obesity, and hyperinsulinemia in African-Americans: the Atherosclerosis Risk in Communities Study.

    Lei HH, Coresh J, Shuldiner AR, Boerwinkle E, Brancati FL.

    Diabetes. 1999 Sep;48(9):1868-72.PMID: 10480621 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    The insulin receptor substrate-1 Gly972Arg polymorphism is not associated with Type 2 diabetes mellitus in two population-based studies.

    van Dam RM, Hoebee B, Seidell JC, Schaap MM, Blaak EE, Feskens EJ.

    Diabet Med. 2004 Jul;21(7):752-8.PMID: 15209769 [PubMed - indexed for MEDLINE]Related articles

    3.

    Metabolic effects of the Gly1057Asp polymorphism in IRS-2 and interactions with obesity.

    Stefan N, Kovacs P, Stumvoll M, Hanson RL, Lehn-Stefan A, Permana PA, Baier LJ, Tataranni PA, Silver K, Bogardus C.

    Diabetes. 2003 Jun;52(6):1544-50.PMID: 12765968 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    The G972R variant of the insulin receptor substrate-1 (IRS-1) gene, body fat distribution and insulin-resistance.

    Baroni MG, Arca M, Sentinelli F, Buzzetti R, Capici F, Lovari S, Vitale M, Romeo S, Di Mario U.

    Diabetologia. 2001 Mar;44(3):367-72.PMID: 11317670 [PubMed - indexed for MEDLINE]Related articles

    5.

    Molecular scanning for mutations in the insulin receptor substrate-1 (IRS-1) gene in Mexican Americans with Type 2 diabetes mellitus.

    Celi FS, Negri C, Tanner K, Raben N, De Pablo F, Rovira A, Pallardo LF, Martin-Vaquero P, Stern MP, Mitchell BD, Shuldiner AR.

    Diabetes Metab Res Rev. 2000 Sep-Oct;16(5):370-7.PMID: 11025561 [PubMed - indexed for MEDLINE]Related articles

    6.

    Prevalence of variants in candidate genes for type 2 diabetes mellitus in The Netherlands: the Rotterdam study and the Hoorn study.

    Hart LM, Stolk RP, Dekker JM, Nijpels G, Grobbee DE, Heine RJ, Maassen JA.

    J Clin Endocrinol Metab. 1999 Mar;84(3):1002-6.PMID: 10084586 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    SNP43 of CAPN10 and the risk of type 2 Diabetes in African-Americans: the Atherosclerosis Risk in Communities Study.

    Garant MJ, Kao WH, Brancati F, Coresh J, Rami TM, Hanis CL, Boerwinkle E, Shuldiner AR; Atherosclerosis Risk in Communities Study.

    Diabetes. 2002 Jan;51(1):231-7.PMID: 11756346 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    The association of Ala54Thr variant of intestinal fatty acid binding protein gene with general and regional adipose tissue depots.

    Kunsan X, Taisan Z, Weiping J, Duoqi S, Wei D, Jie L, Junxi L, Rong Z.

    Chin Med Sci J. 1999 Mar;14(1):46-51.PMID: 12899384 [PubMed - indexed for MEDLINE]Related articles

    9.

    Thr54 allele carriers of the Ala54Thr variant of FABP2 gene have associations with metabolic syndrome and hypertriglyceridemia in urban South Indians.

    Vimaleswaran KS, Radha V, Mohan V.

    Metabolism. 2006 Sep;55(9):1222-6.PMID: 16919542 [PubMed - indexed for MEDLINE]Related articles

    10.

    Interaction between the G1057D variant of IRS-2 and overweight in the pathogenesis of type 2 diabetes.

    Mammarella S, Romano F, Di Valerio A, Creati B, Esposito DL, Palmirotta R, Capani F, Vitullo P, Volpe G, Battista P, Della Loggia F, Mariani-Costantini R, Cama A.

    Hum Mol Genet. 2000 Oct 12;9(17):2517-21.PMID: 11030756 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Relationship of insulin receptor substrate-1 and -2 genotypes to phenotypic features of polycystic ovary syndrome.

    Ehrmann DA, Tang X, Yoshiuchi I, Cox NJ, Bell GI.

    J Clin Endocrinol Metab. 2002 Sep;87(9):4297-300.PMID: 12213887 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Pro12Ala of the peroxisome proliferator-activated receptor-gamma2 gene is associated with lower serum insulin levels in nonobese African Americans: the Atherosclerosis Risk in Communities Study.

    Kao WH, Coresh J, Shuldiner AR, Boerwinkle E, Bray MS, Brancati FL; Atherosclerosis Risk in Communities Study.

    Diabetes. 2003 Jun;52(6):1568-72.PMID: 12765972 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Polymorphisms in the insulin receptor substrate-1 (IRS-1) gene and the insulin receptor substrate-2 (IRS-2) gene influence glucose homeostasis and body mass index in women with polycystic ovary syndrome and non-hyperandrogenic controls.

    Villuendas G, Botella-Carretero JI, Roldán B, Sancho J, Escobar-Morreale HF, San Millán JL.

    Hum Reprod. 2005 Nov;20(11):3184-91. Epub 2005 Jul 21.PMID: 16037106 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    A study on the genetics of obesity: influence of polymorphisms of the beta-3-adrenergic receptor and insulin receptor substrate 1 in relation to weight loss, waist to hip ratio and frequencies of common cardiovascular risk factors.

    Benecke H, Topak H, von zur Mühlen A, Schuppert F.

    Exp Clin Endocrinol Diabetes. 2000;108(2):86-92.PMID: 10826514 [PubMed - indexed for MEDLINE]Related articles

    15.

    Common amino acid substitutions in insulin receptor substrate-4 are not associated with Type II diabetes mellitus or insulin resistance.

    Almind K, Frederiksen SK, Ahlgren MG, Urhammer S, Hansen T, Clausen JO, Pedersen O.

    Diabetologia. 1998 Aug;41(8):969-74.PMID: 9726601 [PubMed - indexed for MEDLINE]Related articles

    16.

    The Arg972 variant in insulin receptor substrate-1 is associated with an increased risk of secondary failure to sulfonylurea in patients with type 2 diabetes.

    Sesti G, Marini MA, Cardellini M, Sciacqua A, Frontoni S, Andreozzi F, Irace C, Lauro D, Gnasso A, Federici M, Perticone F, Lauro R.

    Diabetes Care. 2004 Jun;27(6):1394-8.PMID: 15161794 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Obesity, Type II diabetes and the Ala54Thr polymorphism of fatty acid binding protein 2 in the Tongan population.

    Duarte NL, Colagiuri S, Palu T, Wang XL, Wilcken DE.

    Mol Genet Metab. 2003 Jul;79(3):183-8.PMID: 12855223 [PubMed - indexed for MEDLINE]Related articles

    18.

    [The influence of polymorphism the Gly972Arg variant insulin receptor substrate-1 (IRS-1) gene, and G-308A TNF-alpha gene on obesity and insulin resistance in children with obesity]

    Pyrzak B, Wiśniewska A, Rymkiewicz-Kluczyńska B.

    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw. 2006;12(3):175-8. Polish. PMID: 17020651 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    The haplotypes of the IRS-2 gene affect insulin sensitivity in Japanese patients with type 2 diabetes.

    Okazawa K, Yoshimasa Y, Miyamoto Y, Takahashi-Yasuno A, Miyawaki T, Masuzaki H, Hayashi T, Hosoda K, Inoue G, Nakao K.

    Diabetes Res Clin Pract. 2005 Apr;68(1):39-48.PMID: 15811564 [PubMed - indexed for MEDLINE]Related articles

    20.

    Interaction of the G protein beta 3 subunit T825 allele and the IRS-1 Arg972 variant in type 2 diabetes.

    Rosskopf D, Frey U, Eckhardt S, Schmidt S, Ritz E, Hofmann S, Jaksch M, Müller N, Hüsing J, Siffert W, Jöcke KH.

    Eur J Med Res. 2000 Nov 30;5(11):484-90.PMID: 11121369 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity